Concord Medical Services Holdings Ltd (CCM), a Cayman Islands-based company, operates in the healthcare industry, specifically focusing on comprehensive cancer care and management services in China. Concord Medical's primary business activities encompass hospital operations, medical equipment leasing and management, and medical information technology services. These activities are carried out in China, a region with a growing demand for cancer care and management services. The company generates revenue through its hospital operations, medical...
No data available.
No data available.
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | HCA | HCA Healthcare, Inc. | 114.88 Bn | 18.11 | 1.54 | 46.35 Bn |
| 2 | THC | Tenet Healthcare Corp | 18.07 Bn | 13.34 | 0.87 | 13.19 Bn |
| 3 | UHS | Universal Health Services Inc | 14.64 Bn | 10.65 | 0.86 | 5.11 Bn |
| 4 | FMS | Fresenius Medical Care AG | 14.10 Bn | 16.69 | 0.61 | 14.98 Bn |
| 5 | EHC | Encompass Health Corp | 12.55 Bn | 19.95 | 2.17 | 2.66 Bn |
| 6 | ENSG | Ensign Group, Inc | 10.08 Bn | 30.72 | 2.09 | 2.16 Bn |
| 7 | DVA | Davita Inc. | 8.90 Bn | 11.53 | 0.67 | 12.78 Bn |
| 8 | CHE | Chemed Corp | 6.38 Bn | 22.87 | 2.52 | 0.14 Bn |
| Current Valuation | Value | Ind Avg | Percentile |
|---|---|---|---|
| EV to Assets EV to Assets | 0.05 | 1.26 | |
| EV to Cash from Ops. EV/CFO | -0.90 | 12.78 | |
| EV to Debt EV to Debt | 0.09 | 12.10 | |
| EV to EBIT EV/EBIT | 1.28 | 10.74 | |
| EV to EBITDA EV/EBITDA | 0.68 | 16.04 | |
| EV to Free Cash Flow [EV/FCF] EV/FCF | -0.44 | 18.02 | |
| EV to Market Cap EV to Market Cap | 71.80 | 432.64 | |
| EV to Revenue EV/Rev | 0.60 | 2.77 | |
| Price to Book Value [P/B] P/B | 0.00 | -1.92 | |
| Price to Earnings [P/E] P/E | -0.74 | 5.13 |
| Dividend Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Dividend Coverage Ratio Dividend Coverage Ratio | 0.00 | 0.10 | |
| Dividend Payout Ratio % Dividend Payout Ratio % | 0.00 | -13.44 | |
| Dividend per Basic Share Div per Share (Qtr) | 0.00 | 0.27 | |
| FCF Dividend Payout Ratio % FCF Dividend Payout Ratio % | 0.00 | 5.42 | |
| Interest Coverage Int. cover (Qtr) | 0.98 | -97.94 |
| Growth Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Capex Growth (1y) % Capex Growth (1y) % | 0.00 | -114.65 | |
| Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) | 58.63 | 65.22 | |
| Dividend Growth (1y) % Dividend Growth (1y) % | 0.00 | 0.97 | |
| EBIAT Growth (1y) % EBIAT 1y % (Qtr) | 917.96 | -46.98 | |
| EBITDA Growth (1y) % EBITDA Growth (1y) % | 0.00 | 75.97 | |
| EBIT Growth (1y) % EBIT 1y % (Qtr) | 577.34 | -61.19 | |
| EBT Growth (1y) % EBT 1y % (Qtr) | 98.49 | -115.48 | |
| EPS Growth (1y) % EPS Growth (1y) % | 56.33 | -24.32 | |
| FCF Growth (1y) % FCF Growth (1y) % | 0.00 | 309.51 | |
| Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) | -23.32 | 17.88 |
| Liquidity Ratios | Value | Ind Avg | Percentile |
|---|---|---|---|
| Asset Utilization Ratio Asset Util Ratio (Qtr) | 0.01 | 1.04 | |
| Cash Payout Ratio Cash Payout Ratio | 0.00 | 0.04 | |
| Cash Ratio Cash Ratio (Qtr) | 0.08 | 0.39 | |
| Current Ratio Curr Ratio (Qtr) | 0.42 | 1.39 | |
| Debt to Equity Ratio Debt/Equity (Qtr) | -1.71 | -13.19 | |
| Interest Cover Ratio Int Coverage (Qtr) | 0.98 | -97.94 | |
| Times Interest Earned Times Interest Earned (Qtr) | 0.98 | -97.94 |
| Profitability | Value | Ind Avg | Percentile |
|---|---|---|---|
| EBITDA Margin % EBITDA Margin % | 0.00 | -95.81 | |
| EBIT Margin % EBIT Margin % (Qtr) | 340.05 | -94.97 | |
| EBT Margin % EBT Margin % (Qtr) | -0.75 | -105.60 | |
| Gross Margin % Gross Margin % (Qtr) | 144.20 | 23.31 | |
| Net Profit Margin % Net Margin % (Qtr) | -1.10 | -106.14 |